3726 - 3750 of 8808 Results
Title
Year
-
OPENTitle: BDNF rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1053591Best OA location URL: https://doi.org/10.3389/fneur.2022.1053591Citation Count: 1
-
OPENTitle: Subcortical Intermittent Theta-Burst Stimulation (iTBS) Increases Theta-Power in Dorsolateral Prefrontal Cortex (DLPFC)Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00041Best OA location URL: https://doi.org/10.3389/fnins.2020.00041Citation Count: 30
-
RESTRICTEDTitle: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 82Issue #: 10_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p1.016Citation Count: 0
-
OPENTitle: Distinct alterations in Parkinson's medication-state and disease-state connectivityJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 16Issue #:Start Page: 575End Page: 585Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.09.004Best OA location URL: https://doi.org/10.1016/j.nicl.2017.09.004Citation Count: 44
-
OPENTitle: NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathyJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 117Issue #: 3Start Page: 1762End Page: 1771Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1909110117Best OA location URL: https://www.pnas.org/content/pnas/117/3/1762.full.pdfCitation Count: 116
-
RESTRICTEDTitle: Impact of inpatient mobility on outcomes in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 135Issue #:Start Page: 107834End Page: 107834Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107834Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.107834Citation Count: 0
-
OPENTitle: PINK1 Phosphorylates MIC60/Mitofilin to Control Structural Plasticity of Mitochondrial Crista JunctionsJournal Name: Molecular CellPublisher: Elsevier BVVol: 69Issue #: 5Start Page: 744End Page: 756.e6Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molcel.2018.01.026Best OA location URL: http://www.cell.com/article/S1097276518300558/pdfCitation Count: 100
-
OPENTitle: Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 42Issue #: 3Start Page: 327End Page: 340Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.01.024Best OA location URL: https://lup.lub.lu.se/record/1831976Citation Count: 169
-
RESTRICTEDTitle: Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-008Citation Count: 0
-
RESTRICTEDTitle: The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 2Start Page: 273End Page: 293Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29688Citation Count: 8
-
RESTRICTEDTitle: Combined assessment of blood glucocerebrosidase activity and α-synuclein levels in GBA1 mutation carriers: A novel potential biomarkerJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 135Issue #:Start Page: 107854End Page: 107854Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107854Citation Count: 0
-
RESTRICTEDTitle: The meaning of a “hippo” response on the Montreal Cognitive Assessment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 19Issue #: 4Start Page: 463End Page: 465Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.09.005Citation Count: 1
-
RESTRICTEDTitle: Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 39End Page: 42Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.019Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.06.019Citation Count: 1
-
OPENTitle: Is REM Sleep Behavior Disorder Changing? Secular Changes Versus Referral PatternsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 10Start Page: 1519End Page: 1524Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.13842Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13842Citation Count: 2
-
OPENTitle: Generation of human midbrain organoids from induced pluripotent stem cellsJournal Name: MNI Open ResearchPublisher: F1000 Research LtdVol: 3Issue #:Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.12688/mniopenres.12816.1Best OA location URL: https://mniopenresearch.org/articles/3-1/v1/pdfCitation Count: 12
-
RESTRICTEDTitle: High priority publications on Parkinson's disease in 2017Journal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 1Start Page: 8End Page: 10Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(17)30416-7Citation Count: 0
-
OPENTitle: Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synucleinJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01283-7Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-021-01283-7Citation Count: 21
-
OPENTitle: Sea cucumber-derived extract can protect skin cells from oxidative DNA damage and mitochondrial degradation, and promote wound healingJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 180Issue #:Start Page: 117466End Page: 117466Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.biopha.2024.117466Best OA location URL: https://doi.org/10.1016/j.biopha.2024.117466Citation Count: 1
-
OPENTitle: Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrilsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 129Issue #:Start Page: 67End Page: 78Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2019.05.012Best OA location URL: https://www.sciencedirect.com/science/article/pii/S096999611930124XCitation Count: 63
-
OPENTitle: Comparative Protein Interaction Network Analysis Identifies Shared and Distinct Functions for the Human ROCO ProteinsJournal Name: PROTEOMICSPublisher: WileyVol: 18Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/pmic.201700444Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pmic.201700444Citation Count: 44
-
RESTRICTEDTitle: The emerging role of SMPD1 mutations in Parkinson's disease: Implications for future studiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 10Start Page: 1294End Page: 1295Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.018Citation Count: 40
-
OPENTitle: Microscopic Viscosity of Neuronal Plasma Membranes Measured Using Fluorescent Molecular Rotors: Effects of Oxidative Stress and NeuroprotectionJournal Name: ACS Applied Materials & InterfacesPublisher: American Chemical Society (ACS)Vol: 11Issue #: 40Start Page: 36307End Page: 36315Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsami.9b10426Citation Count: 50
-
OPENTitle: Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsiesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-016-0305-8Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-016-0305-8Citation Count: 69
-
OPENTitle: Lifestyle factors and clinical severity of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-31531-wBest OA location URL: https://www.nature.com/articles/s41598-023-31531-w.pdfCitation Count: 12
-
RESTRICTEDTitle: Intranasal administration of glial-derived neurotrophic factor (GDNF) rapidly and significantly increases whole-brain GDNF level in ratsJournal Name: NeurosciencePublisher: Elsevier BVVol: 303Issue #:Start Page: 569End Page: 576Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2015.07.016Citation Count: 45